Compound information
- Natural Products
- ZC2652941
- Molecular Formula
- C21H30F3N3O2
- Molecular Weight
- 413.22901186 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate
- InChI
- InChI=1S/C21H30F3N3O2/c1-20(2,3)29-19(28)27-12-10-25(11-13-27)15-16-6-7-17(21(22,23)24)14-18(16)26-8-4-5-9-26/h6-7,14H,4-5,8-13,15H2,1-3H3
- InChI Key
- VGHKBHOONDBNAK-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1
- Source
- ZINC000221841749
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 29 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 36.02 Å2 | LogP | 4.722 |
LogS | -4.513 | LogD | 4.402 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.993 | Pgp substrate | 0.768 |
HIA | 0.96 | F20 % | 0.858 |
F30 % | 0.976 | Caco-2 | -4.763 |
MDCK | -5.002 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.987 | PPB | 83.314 |
VD | 3.868 | Fu | 0.641 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.233 | CYP1A2 substrate | 0.507 |
CYP2A6 substrate | 0.706 | CYP2B6 substrate | 0.562 |
CYP2C19 inhibitor | 0.606 | CYP2C19 substrate | 0.563 |
CYP2C8 substrate | 0.419 | CYP2C9 inhibitor | 0.146 |
CYP2C9 substrate | 0.119 | CYP2D6 inhibitor | 0.932 |
CYP2D6 substrate | 0.745 | CYP2E1 substrate | 0.35 |
CYP3A4 inhibitor | 0.17 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.044 | CL | 5.254 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.999 | Hepatotoxicity | 0.974 |
Mutagenicity | 0.104 | Rat Oral Acute Toxicity | 0.659 |
FDAMDD | 0.53 | Skin Sensitization | 0.791 |
Carcinogenicity | 0.034 | Eye Corrosion | 0.001 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.995 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.414 | IGC50 | 4.094 |
LC50FM | 3.823 | LC50DM | 0.018 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.452 | NR-AR-LBD | 0.234 |
NR-AhR | 0.238 | NR-Aromatase | 0.085 |
NR-ER | 0.259 | NR-ER-LBD | 0.485 |
NR-PPAR-gamma | 0.156 | SR-ARE | 0.815 |
SR-ATAD5 | 0.328 | SR-HSE | 0.158 |
SR-MMP | 0.028 | SR-p53 | 0.257 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.